OpenBilldrug price receipt

NADAC week of 2026-10-14

ATAZANAVIR SULFATE 200 MG CAP

For 30 capsules

Pharmacies pay

$33.26 filed

30 × $1.10873 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-08-19 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: The Part D file flags this drug’s average spending per dosage unit as an outlier, so OpenBill does not use it as a reference price. Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.

The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$43.25 estimated

$33.26 + $4.99 (15%) + $5.00 fee per fill = $43.25

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-08-19 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

ATAZANAVIR SULFATE 200 MG CAP is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “atazanavir” and “atazanavir sulfate”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as capsule and its route as oral.

FDA lists 4 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals USA, Inc., Camber Pharmaceuticals, Inc. and Laurus Labs Limited.

FDA’s Established Pharmacologic Class for it is Protease Inhibitor.

The NADAC file of 2026-10-14 prices it under 4 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $33.26 for 30 capsules (30 × $1.10873 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-08-19. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 4, carried forward from the previous file.

The NADAC of all 4 NDCs was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: those prices took effect on 2026-08-19. The file is new; the price is not.

What NADAC measures · Why 30 capsules · NADAC explanation codes · Carried-forward prices

All 4 NDCs

Other strengths, forms and brands

1 other product in the NADAC file shares an FDA nonproprietary name with ATAZANAVIR SULFATE 200 MG CAP.

ProductPharmacies pay per unitMedicare per unit
ATAZANAVIR SULFATE 200 MG CAP this page
generic · capsule		$1.10873 per EA filed
eff. 2026-08-19		We don’t know yet
ATAZANAVIR SULFATE 300 MG CAP
generic · capsule		$2.22639 per EA filed
eff. 2026-09-23		We don’t know yet

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-08-19, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Compared with its class

The middle of its 4 NDCs’ NADAC prices is $1.10873 per EA filed.

Of the 11 other products in FDA’s Protease Inhibitor class priced per EA, 10 have a higher middle NADAC price and 1 a lower one. The one in the middle is NORVIR 100 MG TABLET, at $8.3489 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-08-19, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

We don’t know yet; the card above says why.

Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Its pharmacologic class

Related in the same class

More